TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease - Medsca
<img alt="" height="1" width="1"> TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease Medscape Treatment with subcutaneous infusion (SCI) of the dopamine agonist apomorphine (Britannia Pharmaceuticals) can decrease "off" time in advanced Parkinson's disease (PD), new research suggests. In PD, "off" time refers to the wearing off of a medication ... and more » More... |
All times are GMT -5. The time now is 01:08 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.